高BMP7表达可能会通过改变上皮细胞行为来恶化COPD中的呼吸道疾病
Wenyan Dong1, Mengshuang Xie2, Chunjie Ming3
1Department of General Practice, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.
International journal of chronic obstructive pulmonary disease
|January 13, 2025
概括
骨形态遗传蛋白-7 (BMP7) 在慢性阻塞性肺病 (COPD) 气道中升高,通过抑制细胞增殖和促进异常细胞变化和亡,驱动气道疾病.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 呼吸道疾病是慢性阻塞性肺病 (COPD) 病原体的核心,但其机制仍然不清楚.
- 骨形态遗传蛋白-7 (BMP7),是一种生长因子,调节细胞增殖,分化和亡.
- 之前的研究表明,BMP7在COPD呼吸道上皮质中的表达率很高,但其具体作用尚未完全理解.
研究的目的:
- 研究骨形态遗传蛋白-7 (BMP7) 在慢性阻塞性肺病 (COPD) 的呼吸道疾病中的作用.
- 检查COPD患者呼吸道中的BMP7表达及其与疾病严重程度的相关性.
- 阐明BMP7对人类支气管上皮细胞的功能影响.
主要方法:
- 对COPD患者和对照患者的肺组织和唾液中BMP7表达的分析.
- 人类初级支气管上皮细胞 (HPBECs) 的隔离和培养.
- 评估BMP7对HPBEC增殖,分化和亡的影响,包括对信号通路的调查.
主要成果:
- 与对照组相比,BMP7的表达在COPD支气管上皮细胞和唾液中显著更高.
- 在COPD患者中,增加的BMP7与增加的呼吸道壁厚度和降低的FEV1相关.
- 再组合的BMP7抑制了HPBEC的增殖,促进了平形转化和状细胞分化受损,而BMP7的过度表达通过MK7/JNK2/caspase-3通路诱导了亡.
结论:
- 支气管上皮质中的高BMP7表达有助于COPD呼吸道疾病.
- BMP7通过抑制增殖,促进异常分化和诱导呼吸道上皮细胞过度亡,发挥着关键作用.
- 向BMP7可能为COPD呼吸道病理提供治疗策略.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20COPD: Pathogenesis and Clinical Features
228
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
228
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K